Source: Applied Cancer Research. Conference titles: São Paulo Research Conference-Cancer. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS, APOPTOSE, BIOMARCADORES
ABNT
SILVA PINTO, C. et al. ADAM23 silencing in breast cancer is associated with capase-1 and DAPK-1 downregulation and resistance to anoikis. Applied Cancer Research, v. 27, n. 2, p. 71, 2007Tradução . . Acesso em: 18 fev. 2026.APA
Silva Pinto, C., Verbisck, N. V., Chammas, R., Costa, E. T., Costa, F. F., & Camargo, A. A. (2007). ADAM23 silencing in breast cancer is associated with capase-1 and DAPK-1 downregulation and resistance to anoikis. Applied Cancer Research, 27( 2), 71.NLM
Silva Pinto C, Verbisck NV, Chammas R, Costa ET, Costa FF, Camargo AA. ADAM23 silencing in breast cancer is associated with capase-1 and DAPK-1 downregulation and resistance to anoikis. Applied Cancer Research. 2007 ; 27( 2): 71.[citado 2026 fev. 18 ]Vancouver
Silva Pinto C, Verbisck NV, Chammas R, Costa ET, Costa FF, Camargo AA. ADAM23 silencing in breast cancer is associated with capase-1 and DAPK-1 downregulation and resistance to anoikis. Applied Cancer Research. 2007 ; 27( 2): 71.[citado 2026 fev. 18 ]
